Navigation Links
PET/MR effective for imaging recurrent prostate cancer
Date:6/11/2013

Vancouver, British Columbia When prostate cancer makes a comeback, it becomes increasingly important to have exceptional imaging available to find all possible regions where cancer has spread to other parts of the body, or metastasized, in order to plan the best possible treatment. A relatively new imaging system that simultaneously combines positron emission tomography and magnetic resonance (PET/MR) demonstrates a higher capacity for mapping recurrent prostate cancer than the already high standard of integrated PET and computed tomography (PET/CT), say researchers presenting a study at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.

PET/MR provides superb soft tissue contrast with its MR component, compared to PET/CT, which focuses more on structure and density imaging with CT. This study ushers PET/MR into the ring of clinical practice by exhibiting clear benefits for prostate cancer patients with metastatic tumors.

In this comparative study recurrent prostate cancer is imaged both with PET/MR and PET/CT with the molecular imaging agent C-11 choline, which was approved for this use by the U.S. Food and Drug Administration (FDA) last year. Choline is a naturally occurring B vitamin complex that is avidly bound by prostate cells upon injection, even those that have traveled through the bloodstream and taken up residence to develop metastatic tumors elsewhere, which is especially likely in the lymph nodes and in bone.

"The combination of PET, here with C-11 choline, and functional MRI provides complementary information that increases diagnostic certainty with higher detection rates, especially for more precise localization of recurrence. This could help to better tailor specific therapy, e.g., radiation of the pelvis versus antihormonal therapy, for patients with metastatic prostate cancer," said Matthias Eiber, MD, lead scientist for the study from TU Muenchen in Munich, Germany.

Methodology included a study population of 31 patients who had both PET/CT and PET/MR performed for restaging of recurrent prostate cancer with single injection of the imaging agent C-11 choline. PET/CT scans occurred about five minutes after injection, and PET/MR scans occurred about 51 minutes after injection. Scans were interpreted separately and all detected lesions were categorized according to suspected metastases as definitely, probably or indeterminately metastatic. Researchers discovered that PET/MR found more areas of metastases17 in 12 different patientswhen compared to PET/CT, which found 12 areas of metastases in eight subjects. PET/MR also found more lymph node metastases, 42 versus 39 areas of interest with PET/CT. The same held true for bone metastases, which were detected in 17 areas for five patients with PET/MR and 14 areas for four patients with PET/CT.

Simultaneous PET/MR is comparable toif not more powerful thanPET/CT for recurrent prostate cancer. The only obvious challenge was a longer scan time than PET/CT, but it was found to be tolerable by patients undergoing PET/MR. PET/MR additionally offers considerably lower radiation exposure compared to PET/CT. As many of these patients often get a series of examinations in the course of their disease, despite their high average age, radiation protection could be another argument for the promotion of PET/MR. This molecular imaging technique can now be considered a conceivable alternative to PET/CT for restaging prostate metastases, especially when small local tumor recurrences are involved.

"In principle, whole-body integrated PET/MR is a technique that is officially commercially available; however, so far only a limited number of these scanners have been installed worldwide," said Eiber. "Showing a concrete example of how combining PET and functional MR imaging benefits patients with metastatic prostate cancer could potentially motivate continued PET/MR research in this field."


'/>"/>

Contact: Susan Martonik
smartonik@snmmi.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Heart: Cardiac PET/MR measures up to PET/CT
2. Rihanna Herpes and Lipstick Fiasco Shows Need for Effective Herpes Remedy; polyDNA Recommends Gene-Eden-VIR to Kill Latent Herpes Virus
3. Screening at-risk adolescents for celiac disease proves cost-effective
4. 2013 Report Confirms Effective Cyber Emergency Response Plan is Vital to Slash Data Breach Costs
5. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offer New, Advanced Weight Loss Tips to Rapidly Reduce Weight and Increase Effective Stress Management
6. Everyday Vitamin Nutrition LLC Offers Most Potent and Effective Garcinia Cambogia for Appetite Suppression
7. African Mango Plus is Clinically Proven Effective Formula to Increase the Energy Level of the Body
8. ZetaClear the 2-Step Natural Formula is Now Available to Effectively Fight Against the Nail Fungus
9. Ten-Year Follow-Up by AGH Doctors Confirms Effectiveness of Less-Invasive Surgery for Women With Early Stage Breast Cancer
10. As Peripheral Neuropathy Rises in Numbers, Neuracel Introduces One of the Most Effective Treatments
11. Mount Sinai’s Simulation Lab Proves Effective in Training Anesthesiologists Reentering Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced ... Foundation implement a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR ... specializes in long-term care, Brooke Grove now has the capability to achieve its ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s highly popular SearchLight Spectra ... modeling resource for fluorescence microscopists and optical system designers, enabling The Right Solution, ... spanning the globe, SearchLight has become a tremendously popular tool for the fluorescence ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Healthcare companies ... But they will rapidly reject an outdated healthcare executive resume. , “If you’re a ... at your executive resume and wondering if it’s as ready as you are for ...
(Date:4/27/2017)... Reston, VA (PRWEB) , ... April 27, 2017 ... ... mobile application containerization, today announced an exhibitor sponsorship at MobileIron Live! 2017 ... leaders, and new technologies for an immersive, educational approach to helping organizations maximize ...
(Date:4/27/2017)... ... April 27, 2017 , ... Plastic Surgery Associates is excited to announce ... present at the upcoming Aesthetic Meeting. Held in San Diego, at the San Diego ... Canales will lend their expertise to the Premier Global Hot Topics session, speaking on ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  CVS Pharmacy, the retail division ... new store design to enhance the retail customer ... health-focused products and expanded beauty selections paired with ... discover new offerings. Together with its innovative digital ... the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology: